Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paracetamol (acetaminophen) poisoning

S H Thomas1

  • 1Wolfson Department of Clinical Pharmacology, University of Newcastle upon Tyne, U.K.

Pharmacology & Therapeutics
|October 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Meloidogyne aegracyperi</i> n. sp. (Nematoda: Meloidogynidae), a root-knot nematode parasitizing yellow and purple nutsedge in New Mexico.

Journal of nematology·2021
Same author

Characterizing Agreement in the Level of Interarm Blood Pressure Readings of Adults in the Emergency Department (CALIBRATE Study).

Qatar medical journal·2020
Same author

First Report of Columbia Root-Knot Nematode (Meloidogyne chitwoodi) in Potato in New Mexico.

Plant disease·2019
Same author

First Report of Meloidogyne partityla on Pecan in New Mexico.

Plant disease·2019
Same author

First Record of Meloidogyne partityla on Pecan in Georgia.

Plant disease·2019
Same author

Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma.

Bone marrow transplantation·2015
Same journal

Nipocalimab and other FcRn blockers in neuromuscular disorders.

Pharmacology & therapeutics·2026
Same journal

C26:0-lysophosphatidylcholine in X-linked adrenoleukodystrophy.

Pharmacology & therapeutics·2026
Same journal

The CircRNA/miRNA axis in breast cancer: From molecular mechanisms to clinical translation.

Pharmacology & therapeutics·2026
Same journal

Glymphatic-meningeal lymphatic dysfunction in epilepsy: novel mechanistic insights and therapeutic avenues.

Pharmacology & therapeutics·2026
Same journal

The neurovascular unit under siege: Molecular mechanisms and potential drug target for cerebral edema.

Pharmacology & therapeutics·2026
Same journal

A-type potassium channels in pain signaling: Fundamental mechanisms and pathophysiological roles.

Pharmacology & therapeutics·2026
See all related articles

Intentional paracetamol overdose causes significant illness. This review covers paracetamol toxicity mechanisms, clinical effects, and treatments, including antidotes, to reduce harm.

Area of Science:

  • Toxicology
  • Pharmacology
  • Clinical Medicine

Background:

  • Paracetamol (acetaminophen) overdose is a frequent cause of acute liver injury.
  • Intentional self-harm leading to paracetamol poisoning presents a significant public health challenge.

Purpose of the Study:

  • To review the mechanism of paracetamol toxicity.
  • To outline the clinical manifestations and management strategies for paracetamol poisoning.
  • To identify research priorities for mitigating paracetamol poisoning morbidity and mortality.

Main Methods:

  • Literature review of paracetamol toxicity.
  • Synthesis of clinical data on poisoning effects.
  • Analysis of current treatment guidelines and antidotal therapies.

Related Experiment Videos

Main Results:

  • Paracetamol toxicity results from the metabolic pathway producing a reactive intermediate.
  • Clinical effects range from asymptomatic to severe hepatotoxicity and multi-organ failure.
  • N-acetylcysteine is the established antidote, most effective when administered early.

Conclusions:

  • Understanding paracetamol's toxic mechanism is crucial for effective treatment.
  • Prompt recognition and administration of N-acetylcysteine are key to preventing severe outcomes.
  • Further research should focus on optimizing antidote protocols and identifying novel therapeutic targets.